Nordic Capital to buy Advanz Pharma – PE Hub

0
59

Nordic Capital has agreed to acquire Advanz Pharma Corp, a specialty pharmaceutical company focused on complex medicines in Europe.




.blzbtn { display: inline-block; font-size: 18px; line-height: 26px; font-weight: 500; padding: 8px 15px; text-transform: uppercase; width: 40%; margin: 3px; min-width: 50px; background-color: #F47920; color: #ffffff; text-decoration: none; text-align: center; } @media (max-width: 1018px) { .paywall .blzbtn { display: block; width: 100%; margin-bottom: 13px; } } .blzbtn:hover { background-color: #e58100; text-decoration: none !important; }

To read this article, you need to sign in.

You should only be asked to sign in once. Not the case? Click here


New to PE Hub?

Register now to read this article and more for free.

LEAVE A REPLY

Please enter your comment!
Please enter your name here